Genmab — Januar 2017
-
Novartis Signals Growing Ambitions for CAR-T Cancer Treatments, BBG: https://www.bloomberg.com/news/articles/2017-01-30/novartis-signals-growing-ambitions-for-car-t-cancer-treatments?cmpid=socialflow-twitter-business&utm_content=business&utm_campaign=socialflow-organic&utm_source=twitter&utm_medium=social
-
Det er en cyklisk symbiose mellem AB og danske/skandinaviske banker. Når den ene casher ind køber den anden og når den anden genkøber casher den første ind = alle er glade undtagen private aktører der føler sig manipuleret med, men det er omsætningen nok for høj til. Mange investeringsforeninger har Genmab da de er repræsenteret i forskellige elite-indeks og derfor er det bare et salg af de "samme" aktier gang på gang med forskellige motiver, men generelt er der tale om en processuel strukturel
-

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind